HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

COVAC-1 COVID-19 vaccine

peptide vaccine containing the S1 portion of the SARS-CoV-2 spike protein

Also Known As:

COVAC-1; COVAC-1 vaccine; COVAC-2; COVAC-2 COVID-19 vaccine; COVAC-2 vaccine

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Subunit Vaccines: 1839
      - COVAC-1 COVID-19 vaccine: 2
    - Viral Vaccines: 462
      - COVID-19 Vaccines: 7607
        COVAC-1 COVID-19 vaccine: 2

Experts

1.	Anton, Leonard: 1 article (01/2022)
2.	Bauer, Jens: 1 article (01/2022)
3.	Bilich, Tatjana: 1 article (01/2022)
4.	Denk, Monika: 1 article (01/2022)
5.	Fischer, Imma: 1 article (01/2022)
6.	Heitmann, Jonas S: 1 article (01/2022)
7.	Hörber, Sebastian: 1 article (01/2022)
8.	Jäger, Elke: 1 article (01/2022)
9.	Jäger, Simon: 1 article (01/2022)
10.	Karbach, Julia: 1 article (01/2022)

Related Diseases

1.

11/26/2023 - "Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults."
01/01/2022 - "CoVac-1 is a peptide-based vaccine candidate, composed of SARS-CoV-2 T cell epitopes derived from various viral proteins1,2, combined with the Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG, aiming to induce profound SARS-CoV-2 T cell immunity to combat COVID-19. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Toll-Like Receptor 1
3.	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
4.	Vaccines
5.	Monatide (IMS 3015)